MAM
GILD icon

Magellan Asset Management’s Gilead Sciences GILD Stock Holding History

Magellan Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-180
Closed -$15K – 82
2017
Q3 		$15K Hold
180
– – ﹤0.01% 88
2017
Q2 		$13K Buy
180
+60
+50% +$3.99K ﹤0.01% 87
2017
Q1 		$0 Hold
120
– – ﹤0.01% 74
2016
Q4 		$9K Buy
+120
New +$8.92K ﹤0.01% 84

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Magellan Asset Management's GILD Position: Q4 2017 in Review

Magellan Asset Management sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 180 shares — an estimated $15K sold.

Magellan Asset Management first reported a position in GILD in Q4 2016 and held it in 4 quarters. The position peaked at $15K in Q3 2017. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Magellan Asset Management reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • Magellan Asset Management sold 180 Gilead Sciences shares in Q4 2017, an estimated $15K.
  • Magellan Asset Management first reported a position in Gilead Sciences in Q4 2016 and held it in 4 quarters.
  • Magellan Asset Management's Gilead Sciences position peaked at $15K in Q3 2017.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Magellan Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.